#IATDMCT
Call for SFPT membership! 📣
Some examples of benefits:
>access to the SFPT journals
>possiblity to get granted for European congresses
>special rates for annual meeting
#SFPT #SFPT2027 #IATDMCT #FCP #Therapies #clinical #pharmacology @sfpt-fr.org @therapies.bsky.social
sfpt-fr.org?view=article...
Appel à cotisation 2027
Société Française de Pharmacologie et de Thérapeutique
sfpt-fr.org
October 19, 2026 at 11:05 AM
Great to present our work at the @sfpt-fr.org & IATDMCT Conference 2026 in Rennes 🇫🇷
Many stimulating discussions around precision medicine in antipsychotic treatment, methylphenidate & CFTR modulators.
Special thanks to @florianlemaitre.bsky.social & @jmicallef.bsky.social 😁
September 29, 2026 at 3:53 PM
Consensus Guidance for Beta-Lactam Antibiotic DoseIndividualization in Acutely Ill Patients: Endorsed by the ACCP, ESCMID, ESCMID PK/PD of Anti-Infectives Study Group, IDSA, IATDMCT, SCCM and the SIDP.
Barreto, et al.
Pharmacotherapy, 2026.
accpjournals.onlinelibrary.wiley.com/doi/10.1002/...
Consensus Guidance for Beta‐Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infec...
Beta-lactam antibiotics (beta-lactams) are first-line treatments for most major infectious syndromes in acutely ill patients, with in vitro activity against common pathogens, demonstrated efficacy in....
accpjournals.onlinelibrary.wiley.com
July 24, 2026 at 6:46 AM
We were honoured to organise the 23rd IATDMCT Congress at the Grand Copthorne, bringing together 500+ international scientists & healthcare professionals. #Singapore was the perfect hub for this important scientific gathering!
#IATDMCT2025 #ASCEPT
November 11, 2025 at 5:33 AM
SFPT-IATDMCT annual meeting Rennes 2026: schedule update
#SFPT #IATDMCT #pharmacology #methodology #pharmacoepidemiology #neuropsychopharmacology
sfpt-fr.org/congres-sfpt...

More information about the meeting:
www.iatdmct-sfpt2026.org
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
July 20, 2026 at 9:20 AM
SFPT Call for applications:
Prix ADPC Patrice JAILLON 2026 🏆
Aide à la mobilité 2026 📣
Applications deadline: 20th of August 2026
#SFPT #IATDMCT #award #pharmacology #clinical #methodology #innovation @sfpt-fr.org
sfpt-fr.org?view=article...
sfpt-fr.org?view=article...
Prix ADPC Patrice JAILLON 2026 - Appel à candidatures
Société Française de Pharmacologie et de Thérapeutique
sfpt-fr.org
June 8, 2026 at 9:51 AM
Program
www.iatdmct-sfpt2026.org
April 20, 2026 at 11:32 AM
#IMDX Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando

https://www.stocktitan.net/news/IMDX/insight-molecular-diagnostics-to-showcase-leadership-in-kidney-82irpgjuj503.html
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando
Insight Molecular Diagnostics (NASDAQ:IMDX) announced its participation in two major industry conferences to showcase its GraftAssure™ transplant rejection testing technology. The company will host a symposium at the IATDMCT annual meeting in Singapore (September 21-24) and present at the ASHI annual meeting in Orlando (October 6-10).IMDX will discuss its GraftAssureIQ™ research-use-only test kit and the development of GraftAssureDx™, its clinical kitted test. Both tests measure donor-derived cell-free DNA (dd-cfDNA) for transplant rejection detection. The company plans to submit GraftAssureDx for FDA review by year-end and estimates an addressable market of $1 billion for kitted transplant rejection testing.
www.stocktitan.net
September 24, 2025 at 12:22 PM
Role for therapeutic drug monitoring to reduces pleural effusion rates in chronic myeloid leukaemia patients with DasatinibEvidence from a randomized controlled trial

@SFPT_fr @CNPM_fr @IATDMCT @ansm

onlinelibrary.wiley.com/doi/10.1111/bj…
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
Dasatinib is a second-generation BCR-ABL1 tyrosine kinase inhibitor approved for patients with chronic myeloid leukaemia (CML). Dasatinib 100 mg per day is associated with an increased risk of pleura...
onlinelibrary.wiley.com
November 30, 2024 at 7:11 PM
The registration for the 2026 IATDMCT / SFPT congress in Rennes, 🇫🇷 is open! @IATDMCT @SFPT_fr
We need you from September the 27th to September the 30th for making "Precision Medicine: moving from legend to reality" Register here: lnkd.in/eKuBsrZd
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
January 27, 2026 at 9:33 AM
One strange thing though during this meeting was that strange guy we saw like everywhere. He was pursuing everyone offering 🇧🇪 chocolate! Very weird! Any thought who that can be? 🤣 @christophestove.bsky.social @iatdmct
September 27, 2025 at 8:55 AM
Another excellent @iatdmct meeting in Singapore! Kudos to @jsto7380.bsky.social and Sophie Stocker!
September 26, 2025 at 6:07 AM
It is an honor to become the next president-elect of the @IATDMCT just 10 years after my first meeting! I will also be the next co-chair of #IATDMCT2026 in France 🇫🇷! See you there #TDM and #ClinTox friends!
September 25, 2025 at 7:19 AM
Happy to be back again in Oslo 🇳🇴 for the thesis of our @IATDMCT colleague Ole Martin Drevland. Such a privilege to be invited by my friends @AsbergAnders and @IdaRobertsen.
June 21, 2025 at 8:37 AM
Here we are at the IATDMCT-endorsed “Update in personalized immunosuppression” organized by @edoardomelilli.bsky.social and Nuria Lloberas at Hospital University Bellvitge in Barcelona.
May 16, 2025 at 8:17 AM
Everolimus is #13. If you want to know everything on everolimus #TDM, you may read the #IATDMCT consensus document coordinated by my colleague Satohiro Masuda. The trough target is 3-8 ng/mL and it alllows minimizing calcineurin inhibitor treatment.

pubmed.ncbi.nlm.nih.gov/39331837/
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology - PubMed
The Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology established the second consensus report to guide Therapeutic Dr...
pubmed.ncbi.nlm.nih.gov
December 16, 2024 at 9:37 PM